A06065 Summary:

BILL NOA06065
 
SAME ASNo Same As
 
SPONSORRosenthal L
 
COSPNSRSimon
 
MLTSPNSR
 
Amd §3306, Pub Health L
 
Decriminalizes psilocybin.
Go to top    

A06065 Actions:

BILL NOA06065
 
03/08/2021referred to health
Go to top

A06065 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A6065
 
SPONSOR: Rosenthal L
  TITLE OF BILL: An act to amend the public health law, in relation to decriminalizing psilocybin   PURPOSE: This legislation will decriminalize psilocybin and psilocyn.   SUMMARY OF SPECIFIC PROVISIONS: Section one amends paragraphs 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 and 38 of subdivision (d) of schedule I of section 3306 of the public health law, paragraphs 19, 20, 21, 22, 23, and 24 as added by chapter 664 of the laws of 1985, paragraphs 25, 26, 27, 28, 29, and 30 as added by chapter 589 of the laws of 1996, paragraphs 31 and 32 as added by chapter 457 of the laws of 2006, para- graphs 33, 34 and 35 as added by chapter 370 of the laws of 2015 and paragraphs 36, 37 and 38 as added by section 5 of part BB of chapter 57 and the laws of 2018. Section two establishes the effective date.   JUSTIFICATION: Psilocybin is a naturally occurring chemical compound produced by certain species of mushroom. It is the active ingredient in what are colloquially called "magic mushrooms." In 2018, the United States Food and Drug Administration designated the use of psilocybin as a "break- through therapy for treatment-resistant depression," after reviewing the work of Compass Pathways, which is conducting clinical trials exploring its use in treating severe depression. One study demonstrated that a single dose of psilocybin could assist cancer patients in combating anxiety and dark moods, while others indicated the drug's ability to help people struggling with substance use disorder, addiction to nico- tine and anorexia nervosa. Many cities, including Denver, CO, Santa Cruz, CA, and Oakland, CA, have already decriminalized the use and possession of psilocybin, and New York should do the same. With the opportunity to positively affect the lives of millions suffering with mental health and addiction issues, this bill will decriminalize psilo- cybin and allow further research into the study of the drug and its beneficial uses for treatment.   LEGISLATIVE HISTORY: 2019-20: A.10299 - Referred to Health   FISCAL IMPLICATIONS: Undetermined.   EFFECTIVE DATE: This act shall take effect immediately.
Go to top

A06065 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          6065
 
                               2021-2022 Regular Sessions
 
                   IN ASSEMBLY
 
                                      March 8, 2021
                                       ___________
 
        Introduced  by  M.  of  A. L. ROSENTHAL -- read once and referred to the
          Committee on Health
 
        AN ACT to amend the public health law, in  relation  to  decriminalizing
          psilocybin
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Paragraphs 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29,  30,
     2  31,  32,  33,  34, 35, 36, 37 and 38 of subdivision (d) of schedule I of
     3  section 3306 of the public health law, paragraphs 19, 20, 21, 22, 23 and
     4  24 as added by chapter 664 of the laws of 1985, paragraphs 25,  26,  27,
     5  28, 29 and 30 as added by chapter 589 of the laws of 1996, paragraphs 31
     6  and  32  as  added by chapter 457 of the laws of 2006, paragraphs 33, 34
     7  and 35 as added by chapter 370 of the laws of 2015 and paragraphs 36, 37
     8  and 38 as added by section 5 of part BB of chapter 57  of  the  laws  of
     9  2018, are amended to read as follows:
    10    (19) [Psilocybin.
    11    (20) Psilocyn.
    12    (21)] Tetrahydrocannabinols.  Synthetic  equivalents of the substances
    13  contained in the plant, or in the resinous extractives of cannabis,  sp.
    14  and/or synthetic substances, derivatives, and their isomers with similar
    15  chemical structure and pharmacological activity such as the following:
    16    [/\]  delta  1  cis  or  trans tetrahydrocannabinol, and their optical
    17  isomers
    18    [/\] delta 6 cis or  trans  tetrahydrocannabinol,  and  their  optical
    19  isomers
    20    [/\]  delta  3,  4  cis or trans tetrahydrocannabinol, and its optical
    21  isomers (since nomenclature of these substances is  not  internationally
    22  standardized,  compounds  of  these  structures, regardless of numerical
    23  designation of atomic positions covered).
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00987-02-1

        A. 6065                             2
 
     1    [(22)] (20) Ethylamine analog of phencyclidine.  Some trade  or  other
     2  names:    N-ethyl-1-phenylcyclohexylamine,  (1-phenylcyclohexyl) ethyla-
     3  mine, N-(1-phenylcyclohexyl) ethylamine cyclohexamine, PCE.
     4    [(23)]  (21) Pyrrolidine analog of phencyclidine.  Some trade or other
     5  names 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy, PHP.
     6    [(24)] (22) Thiophene analog of phencyclidine.   Some trade  or  other
     7  names:     1-{1-(2-thienyl)-cyclohexyl}-piperidine,  2-thienylanalog  of
     8  phencyclidine, TPCP, TCP.
     9    [(25)] (23) 3,4-methylenedioxymethamphetamine (MDMA).
    10    [(26)] (24) 3,4-methylendioxy-N-ethylamphetamine   (also   known    as
    11  N-ethyl-alpha-methyl-3,4  (methylenedioxy)) phenethylamine, N-ethyl MDA,
    12  MDE, MDEA.
    13    [(27)]  (25) N-hydroxy-3,4-methylenedioxyamphetamine  (also  known  as
    14  N-hydroxy-alpha-methyl-3,4    (methylenedioxy))    phenethylamine,   and
    15  N-hydroxy MDA.
    16    [(28)]  (26) 1-{1- (2-thienyl)  cyclohexyl}  pyrrolidine.  Some  other
    17  names: TCPY.
    18    [(29)]   (27) Alpha-ethyltryptamine.   Some   trade  or  other  names:
    19  etryptamine;         Monase;         Alpha-ethyl-1H-indole-3-ethanamine;
    20  3- (2-aminobutyl) indole; Alpha-ET or AET.
    21    [(30)]  (28)  2,5-dimethoxy-4-ethylamphetamine.    Some trade or other
    22  names: DOET.
    23    [(31)] (29) 4-Bromo-2,5-dimethoxyphenethylamine.  Some trade or  other
    24  names:   2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane;  alpha-desmethyl
    25  DOB; 2C-B, Nexus.
    26    [(32)] (30) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its
    27  optical isomers, salts and salts of isomers.
    28    [(33)] (31) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)
    29  ethanamine also known as 25I-NBOMe; 2C-I-NBOMe; 25I; or Cimbi-5.
    30    [(34)] (32) 2-(4-chloro-2,5-dimethoxyphenyl)-N-      (2-methoxybenzyl)
    31  ethanamine, also known as 25 CNBOMe; 2C-C-NBOMe; 25C; or Cimbi-82.
    32    [(35)] (33) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-       methoxybenzyl)
    33  ethanamine, also known as, 25 BNBOMe; 2C-B-NBOMe; Cimbi-36.
    34    [(36)] (34) 5-methoxy-N,N-dimethyltryptamine.
    35    [(37)] (35) Alpha-methyltryptamine. Some trade or other names: AMT.
    36    [(38)] (36) 5-methoxy-N,N-diisopropyltryptamine. Some trade  or  other
    37  names: 5-MeO-DIPT.
    38    §  2.  This  act shall take effect on the ninetieth day after it shall
    39  have become a law.
Go to top

A06065 LFIN:

 NO LFIN
Go to top